SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Double E who wrote (678)4/15/1998 12:36:00 PM
From: EmuGreg  Read Replies (1) | Respond to of 4140
 
Rainier, did you notice in the S&P article that the $2 Billion in revenues was just for the initial target group (i.e., low hyperopia)? This doesn't include higher hyperopia (2.5+), presbyopia, or the mother-lode of astigmatism (or the LASIK/PRK repair-work). It also doesn't include machine sales.

But if we just stayed at $2 Billion, being conservative folks, what do we think the valuation range might be?

I noticed that VISX has a 5.3 P/S ratio and that 'ol BEAM is at a 1.9 P/S ratio.

Any comments?

Greg



To: Double E who wrote (678)4/16/1998 12:35:00 PM
From: David Jones  Respond to of 4140
 
Well I was out of town yesterday. Today makes the 7.65 resistance mute.
I'm one to watch support more so that resistance. If 6.5 shows again I would consider it a gift.

Dave
O'ya give me volume and a rising price, and even a monkey like me can make money.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News